Amarendra Pegu

9.0k total citations
31 papers, 1.4k citations indexed

About

Amarendra Pegu is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Amarendra Pegu has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Virology, 19 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Amarendra Pegu's work include HIV Research and Treatment (23 papers), Immune Cell Function and Interaction (15 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Amarendra Pegu is often cited by papers focused on HIV Research and Treatment (23 papers), Immune Cell Function and Interaction (15 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Amarendra Pegu collaborates with scholars based in United States, Switzerland and United Kingdom. Amarendra Pegu's co-authors include John R. Mascola, Todd A. Reinhart, Stephen D. Schmidt, Xuejun Chen, JoAnne L. Flynn, Martha Nason, Nancy L. Haigwood, Ann J. Hessell, Keyun Wang and Srinivas S. Rao and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Amarendra Pegu

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amarendra Pegu United States 18 857 678 518 390 289 31 1.4k
Justin Pollara United States 20 738 0.9× 773 1.1× 386 0.7× 466 1.2× 300 1.0× 58 1.5k
Elise Landais United States 16 358 0.4× 977 1.4× 462 0.9× 266 0.7× 229 0.8× 26 1.6k
Jonathan Richard Canada 30 1.5k 1.7× 1.2k 1.8× 932 1.8× 360 0.9× 308 1.1× 85 2.3k
Julio C. C. Lorenzi United States 20 759 0.9× 554 0.8× 1.0k 1.9× 242 0.6× 205 0.7× 36 1.8k
Andre J. Marozsan United States 25 1.7k 1.9× 733 1.1× 1.2k 2.3× 309 0.8× 334 1.2× 34 2.2k
Christopher Sundling Sweden 20 453 0.5× 984 1.5× 233 0.4× 201 0.5× 168 0.6× 52 1.4k
Frank Weichold United States 22 520 0.6× 711 1.0× 663 1.3× 406 1.0× 70 0.2× 39 1.6k
Laura E. McCoy United Kingdom 21 961 1.1× 701 1.0× 458 0.9× 415 1.1× 421 1.5× 45 1.7k
Arman Bashirova United States 22 587 0.7× 1.4k 2.1× 323 0.6× 235 0.6× 115 0.4× 32 1.9k

Countries citing papers authored by Amarendra Pegu

Since Specialization
Citations

This map shows the geographic impact of Amarendra Pegu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amarendra Pegu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amarendra Pegu more than expected).

Fields of papers citing papers by Amarendra Pegu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amarendra Pegu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amarendra Pegu. The network helps show where Amarendra Pegu may publish in the future.

Co-authorship network of co-authors of Amarendra Pegu

This figure shows the co-authorship network connecting the top 25 collaborators of Amarendra Pegu. A scholar is included among the top collaborators of Amarendra Pegu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amarendra Pegu. Amarendra Pegu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weiner, Joshua A., Harini Natarajan, Eun Sung Yang, et al.. (2024). Selection of positive controls and their impact on anti-drug antibody assay performance. Journal of Immunological Methods. 528. 113657–113657. 3 indexed citations
2.
Kwon, Young Do, Amarendra Pegu, Eun Sung Yang, et al.. (2023). Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain. mAbs. 15(1). 2223350–2223350. 2 indexed citations
3.
Dias, Joana, Giulia Fabozzi, Mangaiarkarasi Asokan, et al.. (2021). Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging. Journal of Clinical Investigation. 131(17). 4 indexed citations
4.
Kwon, Young Do, Mangaiarkarasi Asokan, Jason Gorman, et al.. (2021). A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention. mAbs. 13(1). 1946918–1946918. 13 indexed citations
5.
Wen, Jing, Lan Wang, Di Wu, et al.. (2021). Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques. PLoS Pathogens. 17(7). e1009738–e1009738. 9 indexed citations
6.
Hsu, Denise C., Alexandra Schuetz, Rawiwan Im‐Erbsin, et al.. (2021). TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption. PLoS Pathogens. 17(2). e1009339–e1009339. 34 indexed citations
7.
Chuang, Gwo-Yu, Mangaiarkarasi Asokan, Vera B. Ivleva, et al.. (2020). Removal of variable domain N -linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies. mAbs. 12(1). 1836719–1836719. 3 indexed citations
8.
Pegu, Amarendra, et al.. (2020). Anti-HIV-1 Antibodies: An Update. BioDrugs. 34(2). 121–132. 8 indexed citations
9.
Liu, Qingbo, Yen‐Ting Lai, Peng Zhang, et al.. (2019). Improvement of antibody functionality by structure-guided paratope engraftment. Nature Communications. 10(1). 721–721. 26 indexed citations
10.
Pegu, Amarendra, Bhavesh Borate, Yunda Huang, et al.. (2019). A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge. Cell Host & Microbe. 26(3). 336–346.e3. 56 indexed citations
11.
Calenda, Giulia, Ines Frank, Amarendra Pegu, et al.. (2019). Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques. PLoS Pathogens. 15(5). e1007776–e1007776. 11 indexed citations
12.
Crooks, Ema T., Samantha L. Grimley, Michelle D. Cully, et al.. (2018). Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation. PLoS Pathogens. 14(5). e1007024–e1007024. 19 indexed citations
13.
Huang, Yunda, Shelly Karuna, Lindsay N. Carpp, et al.. (2018). Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials. Human Vaccines & Immunotherapeutics. 14(9). 2116–2127. 17 indexed citations
14.
Ferrando‐Martínez, Sara, Eirini Moysi, Amarendra Pegu, et al.. (2018). Accumulation of follicular CD8+ T cells in pathogenic SIV infection. Journal of Clinical Investigation. 128(5). 2089–2103. 43 indexed citations
15.
Fabozzi, Giulia, Amarendra Pegu, Richard A. Koup, & Constantinos Petrovas. (2018). Bispecific antibodies: Potential immunotherapies for HIV treatment. Methods. 154. 118–124. 15 indexed citations
16.
Gautam, Rajeev, Yoshiaki Nishimura, Amarendra Pegu, et al.. (2016). A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature. 533(7601). 105–109. 219 indexed citations
17.
Pegu, Amarendra, Mangaiarkarasi Asokan, Lan Wu, et al.. (2015). Activation and lysis of human CD4 cells latently infected with HIV-1. Nature Communications. 6(1). 8447–8447. 75 indexed citations
18.
Rappocciolo, Giovanna, Heather R. Hensler, Mariel Jais, et al.. (2008). Human Herpesvirus 8 Infects and Replicates in Primary Cultures of Activated B Lymphocytes through DC-SIGN. Journal of Virology. 82(10). 4793–4806. 106 indexed citations
19.
Pegu, Amarendra, Shulin Qin, Beth A. Fallert Junecko, et al.. (2008). Human Lymphatic Endothelial Cells Express Multiple Functional TLRs. The Journal of Immunology. 180(5). 3399–3405. 90 indexed citations
20.
Pegu, Amarendra, JoAnne L. Flynn, & Todd A. Reinhart. (2007). Afferent and Efferent Interfaces of Lymph Nodes Are Distinguished by Expression of Lymphatic Endothelial Markers and Chemokines. Lymphatic Research and Biology. 5(2). 91–104. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin Pollara Breakdown of academic impact, for papers by Elise Landais Breakdown of academic impact, for papers by Jonathan Richard Breakdown of academic impact, for papers by Julio C. C. Lorenzi Breakdown of academic impact, for papers by Andre J. Marozsan Breakdown of academic impact, for papers by Christopher Sundling Breakdown of academic impact, for papers by Frank Weichold Breakdown of academic impact, for papers by Laura E. McCoy Breakdown of academic impact, for papers by Arman Bashirova
Rankless by CCL
2026